Naloxone-induced suppression of food intake in normal and hypothalamic obese rats. 1979

B M King, and F X Castellanos, and A J Kastin, and M C Berzas, and M D Mauk, and G A Olson, and R D Olson

Intraperitoneal injections of naloxone hydrochloride (1, 2, 4, and 8 mg/kg) suppressed food intake in both normal and hypothalamic obese rats maintained on a 4-hr per day feeding schedule. The decrease in feeding was more pronounced in the animals with ventromedial hypothalamic lesions. Appetitively motivated feeding, i.e., the consumption of sweetened milk under nondeprived conditions, was also suppressed by naloxone, but there was no reliable difference between groups. It is concluded that opiate receptors located in the ventromedial hypothalamus are not essential for the effects of opiate agonists and antagonists on feeding behavior.

UI MeSH Term Description Entries
D007031 Hypothalamus Ventral part of the DIENCEPHALON extending from the region of the OPTIC CHIASM to the caudal border of the MAMMILLARY BODIES and forming the inferior and lateral walls of the THIRD VENTRICLE. Lamina Terminalis,Preoptico-Hypothalamic Area,Area, Preoptico-Hypothalamic,Areas, Preoptico-Hypothalamic,Preoptico Hypothalamic Area,Preoptico-Hypothalamic Areas
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D005247 Feeding Behavior Behavioral responses or sequences associated with eating including modes of feeding, rhythmic patterns of eating, and time intervals. Dietary Habits,Eating Behavior,Faith-based Dietary Restrictions,Feeding Patterns,Feeding-Related Behavior,Food Habits,Diet Habits,Eating Habits,Behavior, Eating,Behavior, Feeding,Behavior, Feeding-Related,Behaviors, Eating,Behaviors, Feeding,Behaviors, Feeding-Related,Diet Habit,Dietary Habit,Dietary Restriction, Faith-based,Dietary Restrictions, Faith-based,Eating Behaviors,Eating Habit,Faith based Dietary Restrictions,Faith-based Dietary Restriction,Feeding Behaviors,Feeding Pattern,Feeding Related Behavior,Feeding-Related Behaviors,Food Habit,Habit, Diet,Habit, Dietary,Habit, Eating,Habit, Food,Habits, Diet,Pattern, Feeding,Patterns, Feeding,Restrictions, Faith-based Dietary
D005260 Female Females
D005508 Food Deprivation The withholding of food in a structured experimental situation. Deprivation, Food,Deprivations, Food,Food Deprivations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

B M King, and F X Castellanos, and A J Kastin, and M C Berzas, and M D Mauk, and G A Olson, and R D Olson
February 1978, Behavioral biology,
B M King, and F X Castellanos, and A J Kastin, and M C Berzas, and M D Mauk, and G A Olson, and R D Olson
January 1978, Proceedings of the Western Pharmacology Society,
B M King, and F X Castellanos, and A J Kastin, and M C Berzas, and M D Mauk, and G A Olson, and R D Olson
November 1979, Pharmacology, biochemistry, and behavior,
B M King, and F X Castellanos, and A J Kastin, and M C Berzas, and M D Mauk, and G A Olson, and R D Olson
July 1978, Physiology & behavior,
B M King, and F X Castellanos, and A J Kastin, and M C Berzas, and M D Mauk, and G A Olson, and R D Olson
May 1979, Life sciences,
B M King, and F X Castellanos, and A J Kastin, and M C Berzas, and M D Mauk, and G A Olson, and R D Olson
June 2014, Neuropeptides,
B M King, and F X Castellanos, and A J Kastin, and M C Berzas, and M D Mauk, and G A Olson, and R D Olson
July 1982, The Journal of clinical endocrinology and metabolism,
B M King, and F X Castellanos, and A J Kastin, and M C Berzas, and M D Mauk, and G A Olson, and R D Olson
September 1953, The Yale journal of biology and medicine,
B M King, and F X Castellanos, and A J Kastin, and M C Berzas, and M D Mauk, and G A Olson, and R D Olson
January 2019, Psychosomatic medicine,
B M King, and F X Castellanos, and A J Kastin, and M C Berzas, and M D Mauk, and G A Olson, and R D Olson
December 1983, Physiology & behavior,
Copied contents to your clipboard!